Discontinued — last reported Q4 '25
The Travelers Companies Interest Paid decreased by 30.9% to $94.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.1%, from $61.00M to $94.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 3.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.00M | $59.00M | $115.00M | $59.00M | $115.00M | $60.00M | $115.00M | $60.00M | $115.00M | $59.00M | $136.00M | $60.00M | $135.00M | $60.00M | $135.00M | $61.00M | $136.00M | $60.00M | $136.00M | $94.00M |
| QoQ Change | — | -43.3% | +94.9% | -48.7% | +94.9% | -47.8% | +91.7% | -47.8% | +91.7% | -48.7% | +130.5% | -55.9% | +125.0% | -55.6% | +125.0% | -54.8% | +123.0% | -55.9% | +126.7% | -30.9% |
| YoY Change | — | — | — | — | +10.6% | +1.7% | +0.0% | +1.7% | +0.0% | -1.7% | +18.3% | +0.0% | +17.4% | +1.7% | -0.7% | +1.7% | +0.7% | +0.0% | +0.7% | +54.1% |